Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR.

ABSTRACT:

SUBMITTER: Kim S 

PROVIDER: S-EPMC8732299 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature